Tissue & Cell Technologies Limited
12015631
Details
Compliance
Last accounts
30/09/2023
unaudited abridged
Next accounts due
30/06/2025
Confirmation statement
Last: 01/03/2024
Due 15/03/2025
Industry
Officers
director · Since 15/10/2019
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 71
Also on 7 other boards
Persons with Significant Control
Mr Antony Rabar
British · England · Age 59
Suite 2.20, St John's Innovation Centre, Cambridge, CB4 0WS
Notified 01/09/2022
Former PSCs
Mr Christopher Teng-Boon Tan
Ceased 20/10/2019
Mr Antony Rabar
Ceased 01/09/2022
Mr Alexander John Scott-Barrett
Ceased 10/10/2022
Insolvency History1 case
Andreas Arakapiotis (practitioner) · Kikis Kallis (practitioner)
CompanyRankvs 15+ SIC 86900 peers14
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Insolvency history: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2023
Net Worth
-£2.6M
Balance sheet strength
Cash
£34k
Cash in the bank
Net Current Assets
-£2.9M
Working capital
Current Assets
£413k
Current Liabilities
£3.3M
Fixed Assets
£6k
Debtors
£379k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 0.13 | -£1.3M |
| 2022 | 0.20 | -£580k |
| 2021 | 0.27 | -£397k |
| 2020 | 0.36 | — |
Derived from filed accounts. Not audited figures.